Lv2
191 积分 2023-11-09 加入
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
2天前
已完结
The evolving landscape of obesity pharmacotherapy
3天前
已完结
The expanding landscape of GLP-1 medicines
7天前
已完结
GLP-1 Receptor Agonists
7天前
已完结
GLP-1 Receptor Agonists
7天前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
8天前
已完结
Pan-RAS inhibitor daraxonrasib shows promise in pancreatic cancer
16天前
已完结
The changing landscape of atherosclerosis
18天前
已完结
INTERLEUKIN-6: From Basic Science to Medicine—40 Years in Immunology
18天前
已完结
The IL-1 family of cytokines and receptors in rheumatic diseases
18天前
已完结
皖公网安备34019202002308
